NCT06398769

Brief Summary

Hysterectomy, the most commonly performed gynecological operation, can be carried out through various methods using a wide array of instruments and energy techniques. Minimally invasive procedures such as robotic or laparoscopic approaches are linked to lower perioperative complications and quicker recovery when compared to abdominal hysterectomy. Furthermore, recent advancements in surgical tools and methodologies have facilitated endoscopic surgeries. Uterine manipulation plays a crucial role in laparoscopic hysterectomy by facilitating bladder dissection, positioning the ureters, and exposing the anterior and posterior vaginal fornices. It also prevents pneumoperitoneum loss by closing off the vaginal space. Despite these apparent benefits, there is no existing report comparing different types of uterine manipulators. Therefore, the purpose of this study was to compare the Vcare and SecuFix uterine manipulators used in laparoscopic hysterectomy based on operative time, length of hospital stay, estimated blood loss, perioperative complications, and subjective performance.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2024

Completed
Last Updated

May 3, 2024

Status Verified

May 1, 2024

Enrollment Period

Same day

First QC Date

April 26, 2024

Last Update Submit

May 1, 2024

Conditions

Keywords

uterine manipulatorlaparoscopyInstrumentsminimally invasive surgery

Outcome Measures

Primary Outcomes (1)

  • operative time

    Operation time was defined as the duration from the skin incision to detachment of the uterus.

    Operation time was defined as the duration in minutes from the skin incision to detachment of the uterus during surgery.

Study Arms (2)

SecuFix UM

EXPERIMENTAL

SecuFix UM arm: patients undergoing total laparoscopic hysterectomy

Device: SecuFix UM

VCare UM

ACTIVE COMPARATOR

VCare UM arm: patients undergoing total laparoscopic hysterectomy

Device: VCare UM

Interventions

All surgeries were performed using Secufix UM.

SecuFix UM
VCare UMDEVICE

All surgeries were performed using VCare UM.

VCare UM

Eligibility Criteria

Age35 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 35-65 years
  • hysterectomy for benign gynecological indications

You may not qualify if:

  • history of urogynecologic procedures
  • suspected gynecological malignancy,
  • endometriosis,
  • pelvic inflammatory disease,
  • pelvic organ prolapse,
  • unavailibility of operative records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patients will be unaware that they will undergo an abdominal hysterectomy using VCare or SecuFix for their surgical procedure. Data entry will utilize a coded system within a pre-designed SPSS spreadsheet. A research assistant, who will be independent of the intervention administration, will enter data for each patient using a designated code (1 or 2) that corresponded to the group assignment. All data will send to an independent statistician for blinded analysis.
Purpose
DEVICE FEASIBILITY
Intervention Model
PARALLEL
Model Details: prospective randomized trial
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc Prof, MD, PhD candidate

Study Record Dates

First Submitted

April 26, 2024

First Posted

May 3, 2024

Study Start

May 1, 2024

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

May 3, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

The dataset used and/or analyzed in the study are available from the corresponding author on reasonable request.